Gainers
- Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 199.6% to close at $7.64 on Wednesday after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.
- Hill International, Inc. (NYSE: HIL) shares gained 60.3% to close at $2.79 after Global Infrastructure Solutions (GISI) and the company announced an agreement to merge in an all-cash transaction valued at $173 million.
- Eargo, Inc. (NASDAQ: EAR) jumped 55% to close at $3.13 after climbing 77% on Tuesday. Eargo recently said Q2 EPS results were down year over year.
- Nova LifeStyle, Inc. (NASDAQ: NVFY) gained 41% to settle at $1.10. Nova Lifestyle recently posted Q2 sales of $3.80 million.
- TDH Holdings, Inc. (NASDAQ: PETZ) jumped 38.3% to close at $4.26.
- Cassava Sciences, Inc. (NASDAQ: SAVA) rose 27.3% to close at $25.72 after a form 4 filing showed Director Sanford Robertson purchased 100,000 shares at an average price of $20.69.
- LM Funding America, Inc. (NASDAQ: LMFA) jumped 26.9% to settle at $1.37 after the company reported its Q2 earnings.
- VistaGen Therapeutics, Inc. (NASDAQ: VTGN) rose 23.1% to close at $0.1931.
- VistaGen Therapeutics recently posted a Q1 loss of $0.10 per share.
- Vinco Ventures, Inc. (NASDAQ: BBIG) shares gained 23% to close at $1.39. Vinco Ventures shares jumped around 59% on Tuesday after Nasdaq resumed trading in the stock.
- Laird Superfood, Inc. (NYSE: LSF) climbed 22.2% to close at $2.7501 after the company confirmed the receipt of an unsolicited offer from EF Hutton to acquire all of the company's outstanding common stock for $3 per share in cash.
- Kirkland's, Inc. (NASDAQ: KIRK) climbed 21% to close at $6.40.
- BioVie Inc. (NASDAQ: BIVI) rose 20% to settle at $3.00.
- Spero Therapeutics, Inc. (NASDAQ: SPRO) gained 19.4% to settle at $1.07. Spero Therapeutics recently posted a Q2 loss of $0.87 per share.
- Regis Corporation (NYSE: RGS) rose 19.2% to settle at $1.43. Regis recently amended its credit facility and extended the maturity date from March 23, 2023 to August 31, 2025.
- Histogen Inc. (NASDAQ: HSTO) gained 17.3% to close at $2.17. Histogen recently posted a Q2 loss of $1.55 per share.
- Akumin Inc. (NASDAQ: AKU) gained 17.1% to close at $1.08.
- Talis Biomedical Corporation (NASDAQ: TLIS) rose 16.7% to settle at $0.9804.
- Kubient, Inc. (NASDAQ: KBNT) jumped 14.6% to close at $1.10. Kubient recently reported worse-than-expected Q2 EPS and sales results.
- Stabilis Solutions, Inc. (NASDAQ: SLNG) rose 13.5% to close at $5.21. The company recently posted upbeat quarterly sales.
- ATA Creativity Global (NASDAQ: AACG) gained 13.2% to close at $2.40. ATA Creativity Global recently posted a Q2 loss of $0.05 per share.
- Denbury Inc. (NYSE: DEN) rose 12.4% to settle at $88.72. Denbury is exploring options including a sale, Bloomberg reported.
- LexinFintech Holdings Ltd. (NASDAQ: LX) jumped 12.1% to close at $2.23 after the company late Tuesday reported Q2 results.
- Bed Bath & Beyond Inc (NASDAQ: BBBY) gained 11.8% to settle at $23.08 on continued momentum amid an uptick in retail investor attention on social media.
- Sportradar Group AG (NASDAQ: SRAD) rose 11.6% to close at $13.39 after the company reported better-than-expected Q2 sales results and raised its FY22 sales guidance above analyst estimates.
- Cogent Biosciences, Inc. (NASDAQ: COGT) gained 11.3% to close at $15.76. Cogent Biosciences recently posted a Q2 loss of $0.71 per share.
- HighPeak Energy, Inc. (NASDAQ: HPK) rose 8.9% to settle at $21.46. HighPeak Energy recently posted Q2 EPS of $0.64.
- Global-e Online Ltd. (NASDAQ: GLBE) climbed 7.9% to close at $36.68. Analysts boosted their price targets on Global-E Online.
- BlackLine, Inc. (NASDAQ: BL) gained 7.6% to close at $74.35.
- Agilent Technologies, Inc. (NYSE: A) rose 7.2% to settle at $142.27 after the company reported better-than-expected results for its third quarter and raised its FY22 guidance.
- JE Cleantech Holdings Limited (NASDAQ: JCSE) shares gained 6.6% to close at $2.42 after jumping over 20% on Tuesday.
- Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) rose 5.6% to close at $4.55.
- FaZe Holdings Inc. (NASDAQ: FAZE) rose 5.2% to close at $14.01 after gaining 12% on Tuesday. The company reported Q2 results on Monday.
Losers
- Scienjoy Holding Corporation (NASDAQ: SJ) shares fell 31.1% to close at $3.02 on Wednesday.
- PAVmed Inc. (NASDAQ: PAVM) dropped 30.8% to close at $1.37 after the company issued business update and preliminary Q2 financial results. Lake Street maintained PAVmed with a Buy and lowered the price target from $7 to $5.
- Unity Biotechnology, Inc. (NASDAQ: UBX) fell 29.2% to close at $0.9701 after the company announced a $25 million common stock offering.
- Sonder Holdings Inc. (NASDAQ: SOND) fell 26.3% to close at $1.88.
- Stronghold Digital Mining, Inc. (NASDAQ: SDIG) shares fell 25.4% to close at $2.38 after the company reported worse-than-expected Q2 sales results.
- Endo International plc (NASDAQ: ENDP) fell 23.3% to close at $0.2839. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
- Biomea Fusion, Inc. (NASDAQ: BMEA) declined 22.1% to settle at $10.60. Biomea Fusion recently posted a Q2 loss of $0.59 per share.
- Jowell Global Ltd. (NASDAQ: JWEL) dropped 21.9% to settle at $1.53.
- Palisade Bio, Inc. (NASDAQ: PALI) fell 21.4% to close at $0.1630. Palisade Bio dosed first patient in its Phase 3 study evaluating lead asset LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.
- Embark Technology, Inc. (NASDAQ: EMBK) dipped 20.4% to settle at $13.19. Embark Technology reported the completion of reverse stock split.
- Singular Genomics Systems, Inc. (NASDAQ: OMIC) dropped 20.4% to settle at $3.20 after UBS downgraded the stock from Buy to Neutral and lowered its price target from $10 to $4.50.
- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) fell 19.8% to settle at $0.8101. NeuBase Therapeutics recently posted a Q3 loss of $0.26 per share.
- Iterum Therapeutics plc (NASDAQ: ITRM) declined 19.2% to close at $0.2221. Iterum Therapeutics on Tuesday announced August 17, 2022 as date of 1-for-15 reverse share split.
- Polished.com Inc. (NYSE: POL) dropped 18.6% to close at $0.79. Polished recently issued preliminary Q2 sales guidance below estimates.
- Forza X1, Inc. (NASDAQ: FRZA) fell 18.4% to settle at $6.73 amid continued volatility following Friday's IPO.
- Lucira Health, Inc. (NASDAQ: LHDX) declined 18.4% to close at $2.31. Lucira Health recently reported worse-than-expected Q2 EPS and sales results.
- Kidpik Corp. (NASDAQ: PIK) shares fell 17.4% to close at $2.09 after the company reported worse-than-expected Q2 sales results.
- Esports Entertainment Group, Inc. (NASDAQ: GMBL) dipped 17.4% to settle at $0.5156.
- Nerdy, Inc. (NYSE: NRDY) declined 17.3% to settle at $3.11. Goldman Sachs (NYSE:GS) maintained Nerdy with a Neutral and raised the price target from $3 to $3.5.
- Velo3D, Inc. (NYSE: VLD) dropped 16.6% to close at $4.66. Credit Suisse (SIX:CSGN) initiated coverage on Velo3D with a Neutral rating and announced a price target of $5.4.
- Rubicon Technologies, Inc. (NYSE: RBT) dropped 16.5% to settle at $5.01. Rubicon Technologies recently started trading on the New York Stock Exchange.
- Sema4 Holdings Corp. (NASDAQ: SMFR) fell 16.3% to close at $1.34. Sema4 Holdings recently issued FY22 guidance below estimates.
- Everspin Technologies, Inc. (NASDAQ: MRAM) fell 16.2% to close at $7.32.
- Membership Collective Group Inc. (NYSE: MCG) dropped 15.9% to close at $6.87 after the company lowered FY22 sales forecast.
- Artelo Biosciences, Inc. (NASDAQ: ARTL) shares fell 15.9% to close at $5.35. Artelo Biosciences shares jumped 46% on Tuesday after the company announced the publication of pre-clinical results of its FABP inhibitor platform.
- SIGNA Sports United N.V. (NYSE: SSU) dipped 15.4% to settle at $5.07. SIGNA Sports United recently reported Q3 sales of €324.2 million.
- I-Mab (NASDAQ: IMAB) fell 14.3% to close at $6.83. I-Mab disclosed in an SEC filing that AbbVie Inc (NYSE: NYSE:ABBV) would discontinue the global Phase 1b study of lemzoparlimab combination therapy with azacitidine and venetoclax in myelodysplastic syndrome (MDS) and acute myelocytic leukemia (AML).
- Enovix Corporation (NASDAQ: ENVX) dipped 14.2% to close at $21.41.
- BioAtla, Inc. (NASDAQ: BCAB) fell 14.2% to close at $10.19.
- AMC Entertainment Holdings, Inc. (NYSE: AMC) dropped 13.9% to close at $21.36 as the stock pulled back following recent strength in 'Reddit stocks.'
- Lulu's Fashion Lounge Holdings, Inc. (NASDAQ: LVLU) declined 13.8% to settle at $6.75 after the company reported worse-than-expected Q2 EPS. Piper Sandler lowered its price target on the stock from $14 to $11.
- Latham Group, Inc. (NASDAQ: SWIM) dipped 13.2% to close at $6.78.
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) fell 12.8% to settle at $3.26. Ginkgo Bioworks recently raised FY22 guidance.
- Krispy Kreme, Inc. (NASDAQ: DNUT) fell 12.1% to close at $12.76 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 adjusted EPS and sales guidance below estimates.
- GoodRx Holdings, Inc. (NASDAQ: GDRX) fell 11.9% to close at $6.44. GoodRx recently reported better-than-expected Q2 sales results.
- Farfetch Limited (NYSE: FTCH) declined 11.6% to settle at $8.83.
- The Children's Place, Inc. (NASDAQ: PLCE) fell 11% to close at $48.93 after the company reported a year-over-year drop in Q2 sales.
- Arvinas, Inc. (NASDAQ: ARVN) fell 11% to close at $46.70.
- Blueprint Medicines Corporation (NASDAQ: BPMC) declined 10.8% to close at $61.17 after the company announced top-line results from the registrational Part 2 of the PIONEER clinical trial of AYVAKIT in patients with non-advanced systemic mastocytosis.
- Opendoor (NASDAQ:OPEN) Technologies Inc. (NASDAQ: OPEN) fell 10.5% to close at $5.09.
- Four Seasons Education (Cayman) Inc. (NYSE: FEDU) fell 9.9% to close at $15.95.
- Teva Pharmaceutical Industries Limited (NASDAQ: NYSE:TEVA) fell 9.3% to close at $10.01.
- ZipRecruiter, Inc. (NYSE: ZIP) fell 8.3% to close at $18.18.
- Novavax, Inc. (NASDAQ: NVAX) declined 8.2% to close at $39.37. Novavax Nuvaxovid COVID-19 vaccine was granted expanded provisional approval in New Zealand as a first and second booster for adults.
- Nu Holdings Ltd. (NYSE: NU) fell 8% to settle at $5.08. Nu recently reported better-than-expected Q2 results.
- Lyft , Inc. (NASDAQ: NASDAQ:LYFT) declined 7.1% to close at $17.97.
- The RealReal, Inc. (NASDAQ: REAL) fell 6.2% to close at $3.16 after jumping 22% on Tuesday.
- Zoom Video Communications, Inc. (NASDAQ: ZM) fell 6.2% to close at $102.38. Shares of software companies traded lower amid a rise in treasury yields, which weighed on growth stocks.
- FlexShopper, Inc. (NASDAQ: FPAY) fell 6% to close at $2.37.
- Sanofi (EPA:SASY) (NASDAQ: SNY) fell 5.9% to close at $42.18 after the company announced it is discontinuing the global clinical development program of amcenestrant following the recommendation of an Independent Data Monitoring Committee.
- Snap Inc . (NYSE: NYSE:SNAP) dropped 4.1% to close at $12.09.
Read at Benzinga